Literature DB >> 16424582

Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT.

Paul D Acton1, Andrew Newberg, Karl Plössl, P David Mozley.   

Abstract

This study determined the relative accuracy of diagnosis of Parkinson's disease (PD) using SPECT imaging data, comparing a semi-quantitative region-of-interest (ROI) approach and human observers. A set of patients with PD and normal healthy control subjects were studied using the dopamine transporter tracer [(99m)Tc]TRODAT-1 and SPECT. The sample comprised 81 patients (mean age +/- SD, 63.4 +/- 10.4 years; age range, 39.0-84.2 years) and 94 healthy controls (mean age +/- SD, 61.8 +/- 11.0 years; age range, 40.9-83.3 years). A standardized template containing six ROIs was transposed onto subregions of the brain, and the ratio of striatal to background ROI values was used as a semi-quantitative outcome measure. All images were used in a human observer study, with four experienced investigators. The data from the observer and ROI studies were analysed using a receiver operating characteristic (ROC) analysis, where the area under the ROC curve (AUC) indicated the diagnostic accuracy. ROI analysis and human observers gave similar diagnostic performance (mean observer AUC = 0.89, best ROI AUC = 0.90). This suggested that the human observers are visually acquiring similar information from the images that are contained in the semi-quantitative striatal uptake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424582     DOI: 10.1088/0031-9155/51/3/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's Disease.

Authors:  Eugene Jeong; Sun Young Oh; Kisoo Pahk; Chan-Nyoung Lee; Kun-Woo Park; Jae Sung Lee; Gi Jeong Cheon; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2013-03-26

Review 2.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-05       Impact factor: 3.825

3.  The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism.

Authors:  Koen Van Laere; Ludwig Everaert; Lieven Annemans; Michel Gonce; Wim Vandenberghe; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-02       Impact factor: 9.236

4.  A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements.

Authors:  Eleonora Vanzi; Maria Teresa De Cristofaro; Silvia Ramat; Barbara Sotgia; Mario Mascalchi; Andreas Robert Formiconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-28       Impact factor: 9.236

5.  Analysis of the Effect of Dopamine Transporter Scan on the Diagnosis and Management in a Tertiary Neurology Center.

Authors:  Shakya Bhattacharjee; Vijayashankar Paramanandam; Atrayee Bhattacharya
Journal:  Neurohospitalist       Date:  2019-02-14

6.  Optimization of imaging parameters for SPECT scans of [99mTc]TRODAT-1 using Taguchi analysis.

Authors:  Cheng-Kai Huang; Jay Wu; Kai-Yuan Cheng; Lung-Kwang Pan
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Fully Automated Quantification of the Striatal Uptake Ratio of [(99m)Tc]-TRODAT with SPECT Imaging: Evaluation of the Diagnostic Performance in Parkinson's Disease and the Temporal Regression of Striatal Tracer Uptake.

Authors:  Yu-Hua Dean Fang; Shao-Chieh Chiu; Chin-Song Lu; Tzu-Chen Yen; Yi-Hsin Weng
Journal:  Biomed Res Int       Date:  2015-08-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.